pentoxifylline has been researched along with Alcoholic Fatty Liver in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the utility of liver biopsy in the assessment of clinically severe AH METHODS: The histological features of alcoholic steatohepatitis (ASH) were recorded and scored in patients enrolled in the Steroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH) trial who underwent liver biopsy." | 4.02 | The diagnostic and prognostic significance of liver histology in alcoholic hepatitis. ( Atkinson, S; Austin, A; Forrest, E; Goldin, R; Lloyd, K; Masson, S; Patch, D; Petts, G; Quaglia, A; Thursz, M; Vergis, N; Wright, M, 2021) |
| "Clinicians caring for patients with alcoholic hepatitis (AH) are often confronted with the question of the best pharmacotherapy to be used." | 2.58 | Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. ( Teschke, R, 2018) |
| "Severe alcoholic hepatitis is still associated with high mortality and presence of liver failure manifested by jaundice, coagulopathy and encephalopathy is a poor prognostic indicator." | 2.50 | [Management of severe alcoholic hepatitis]. ( Tilg, H; Wieser, V, 2014) |
| "Pentoxifylline was found to reduce the risk of hepatorenal syndrome, but data on mortality are limited." | 2.49 | Update on the management of alcoholic steatohepatitis. ( Seitz, HK; Stickel, F, 2013) |
| "Alcoholic hepatitis is a disease with a wide range of severity." | 2.44 | Alcoholic steatohepatitis: management and prognosis. ( Maher, JJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Forrest, E | 2 |
| Petts, G | 1 |
| Austin, A | 2 |
| Lloyd, K | 1 |
| Wright, M | 2 |
| Vergis, N | 1 |
| Atkinson, S | 1 |
| Masson, S | 2 |
| Patch, D | 2 |
| Quaglia, A | 1 |
| Thursz, M | 2 |
| Goldin, R | 1 |
| Teschke, R | 1 |
| Stickel, F | 1 |
| Seitz, HK | 1 |
| Wieser, V | 1 |
| Tilg, H | 1 |
| Mellor, J | 1 |
| Stanton, L | 1 |
| Bowers, M | 1 |
| Ryder, P | 1 |
| Day, C | 1 |
| Gleeson, D | 1 |
| O'Grady, J | 1 |
| McCune, A | 1 |
| Richardson, P | 1 |
| Roderick, P | 1 |
| Ryder, S | 1 |
| Casanova, J | 1 |
| Bataller, R | 1 |
| Maher, JJ | 1 |
5 reviews available for pentoxifylline and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options.
Topics: Alcohol Abstinence; Alcohol Dehydrogenase; Catalase; Fatty Liver, Alcoholic; Hepatitis, Alcoholic; H | 2018 |
Update on the management of alcoholic steatohepatitis.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Alcohol Abstinence; Animals; Enteral Nutrition; Fatty Liver | 2013 |
[Management of severe alcoholic hepatitis].
Topics: Alcoholism; Antibodies, Monoclonal; Combined Modality Therapy; Etanercept; Fatty Liver, Alcoholic; F | 2014 |
Alcoholic hepatitis: Prognosis and treatment.
Topics: Alcohol Deterrents; Animals; Antibodies, Monoclonal; Disease Models, Animal; Etanercept; Fatty Liver | 2014 |
Alcoholic steatohepatitis: management and prognosis.
Topics: Adrenal Cortex Hormones; Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Humans; Nutritional Support; | 2007 |
1 trial available for pentoxifylline and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial.
Topics: Clinical Protocols; Double-Blind Method; Fatty Liver, Alcoholic; Glucocorticoids; Humans; Kaplan-Mei | 2013 |
1 other study available for pentoxifylline and Alcoholic Fatty Liver
| Article | Year |
|---|---|
The diagnostic and prognostic significance of liver histology in alcoholic hepatitis.
Topics: Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Humans; Liver; Pentoxifylline; Prognosis; Randomized C | 2021 |